Cutaneous T-cell lymphomas;Kutane T-zell-Lymphome

JDDG - Journal of the German Society of Dermatology

Volumn 1, Issue 12, 2003, Pages 965-981

  Dippel, Edgar ^a   Gellrich, Sylke ^b   Klemkel, Claus Detlev ^a   Goerdt, Sergij ^a   Sterry, Wolfram ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; BEXAROTENE; CARMUSTINE; CD3 ANTIGEN; CD30 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CHLORAMBUCIL; CHLORMETHINE DERIVATIVE; CYCLOPHOSPHAMIDE; CYTOKINE; DENILEUKIN DIFTITOX; DIPEPTIDYL PEPTIDASE IV; DOXORUBICIN; ETRETIN; GEMCITABINE; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 7; METHOTREXATE; PREDNISONE; PROTEIN P53; PSORALEN; RETINOID; STEROID; VINCRISTINE;

ALLERGIC REACTION; ALOPECIA; APOPTOSIS; ASTHENIA; AUTOCRINE EFFECT; BONE MARROW SUPPRESSION; CANCER STAGING; CARDIOTOXICITY; CHROMOSOME ABERRATION; CLINICAL FEATURE; CLINICAL TRIAL; CUTANEOUS T CELL LYMPHOMA; CYTOMEGALOVIRUS; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DISEASE CLASSIFICATION; ENDOCRINE DISEASE; ERYTHRODERMA; FEVER; GASTROINTESTINAL SYMPTOM; GENE REARRANGEMENT; GRANULOMATOUS SKIN DISEASE; HAND FOOT SYNDROME; HISTOPATHOLOGY; HUMAN; HYPERLIPIDEMIA; HYPERURICEMIA; IMMUNOHISTOLOGY; IMMUNOPHENOTYPING; IMMUNOSTIMULATION; LIVER TOXICITY; LUNG TOXICITY; LYMPHOCYTE PROLIFERATION; LYMPHOMATOID PAPULOSIS; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR DYNAMICS; MYCOSIS FUNGOIDES; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; PATHOGENESIS; PERIPHERAL NEUROPATHY; PROGNOSIS; PUVA; RASH; REPRODUCTIVE TOXICITY; REVIEW; SERODIAGNOSIS; SEZARY SYNDROME; SIDE EFFECT; WORINGER KOLOPP DISEASE; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; FEMALE; GERMANY; HUMANS; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MIDDLE AGED; MULTICENTER STUDIES; MYCOSIS FUNGOIDES; NEOPLASM STAGING; PHOTOPHERESIS; PUVA THERAPY; RANDOMIZED CONTROLLED TRIALS; REGISTRIES; SEZARY SYNDROME; SKIN; SKIN NEOPLASMS;

EID: 0345873372     PISSN: 16100379     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0353.2003.03603.x     Document Type: Review

References (25)

1. Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S, Diaz-Perez JL, Geerts ML, Goos M, Knobler R, Ralfkiaer E, Santucci M, Smith N, Wechsler J, Van Vloten WA, Meijer CJ. EORTC classification for primary cutaneous lymphomas: a proposal from the cutaneous lymphomas study group of the European organisation for research and treatment of cancer. Blood 1997; 90: 354-371.
2. Herne KL, Talpur R, Breuer-Mcham J, Champlin R, Duvic M. Cytomegalovirus seropositivity is significantly associated with mycosis fungoides and Sezary syndrome. Blood 2003; 101: 2132-2135.
3. Karenko L, Sarna S, Kahkonen M, Ranki A. Chromosomal abnormalities in relation to clinical disease in patients with cutaneous T-cell lymphoma: a 5-year follow-up study. Br J Dermatol 2003; 148: 55-64.
4. Scarisbrick JJ, Woolford AJ, Russell-Jones R, Whittaker SJ. Allelotyping in mycosis fungoides and Sezary syndrome: common regions of allelic loss identified on 9p, 10q, and 17p. J Invest Dermatol 2001; 117: 663-670.
5. Van Doorn R, Dijkman R, Vermeer MH, Starink TM, Willemze R, Tensen CP. A novel splice variant of the fas gene in patients with cutaneous T-cell lymphoma. Cancer Res J 2002; 62: 5389-5392.
6. Wu K, Lund M, Bang K, Thestrup-Pedersen K. Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma. Cancer 1999; 86: 1056-1063.
7. Dummer R, Dobbeling U, Geertsen R, Willers J, Burg G, Pavlovic J. Interferon resistance of cutaneous T-cell lymphoma-derived clonal T-helper 2 cells allows selective viral replication. Blood 2001; 97: 523-527.
8. Qin JZ, Zhang CL, Kamarashev J, Dummer R, Burg G, Dobbeling U. Interleukin-7 and interleukin-15 regulate the expression of the bcl-2 and c-myb genes in cutaneous T-cell lymphoma cells. Blood 2001; 98: 2778-2783.
9. Berger CL, Hanlon D, Kanada D, Dhodapkar M, Lombillo V, Wang N, Christensen I, Howe G, Crouch J, El-Fishawy P, Edelson R. The growth of cutaneous T-cell lymphoma is stimulated by immature dendritic cells. Blood 2002; 99: 2929-2939.
10. Bagot M, Moretta A, Sivori S, Biassoni R, Cantoni C, Bottino C, Boumsell L, Bensussan A. CD4(+) cutaneous T-cell lymphoma cells express the p140-killer cell immunoglobulin-like receptor. Blood 2001; 97: 1388-1391.
11. Nikolova M, Musette P, Bagot M, Boumsell L, Bensussan A. Engagement of ILT2/CD85j in Sezary syndrome cells inhibits their CD3/TCR signaling. Blood 2002; 100: 1019-1025.
12. Berti E, Tomasini D, Vermeer MH, Meijer CJ, Alessi E, Willemze R. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior. Am J Pathol 1999; 155: 483-492.
13. Beljaards RC, Meijer CJ, Scheffer E, van der Valte P, Willemze R. Differential diagnosis of cutaneous large cell lymphomas using monoclonal antibodies reactive in paraffin-embedded skin biopsy specimens. Am J Dermatopathol 1991; 13: 342-349.
14. Santucci M, Pimpinelli N, Massi D, Kadin ME, Meijer CJ, Muller-Hermelink HK, Paulli M, Wechsler J, Willemze R, Audring H, Bernengo MG, Cerroni L, Chimenti S, Chott A, Diaz-Perez JL, Dippel E, Duncan LM, Feller AC, Geerts ML, Hallermann C, Kempf W, Russell-Jones R, Sander C, Berti E. Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop. Cancer 2003; 97: 610-627.
15. Dippel E, Assaf C, Hummel M, Schrag HJ, Stein H, Goerdt S, Orfanos CE. Clonal T-cell receptor gamma-chain gene rearrangement by PCR-based GeneScan analysis in advanced cutaneous T-cell lymphoma: a critical evaluation. J Pathol 1999; 188: 146-154.
16. Klemke CD, Dippel E, Dembinski A, Pönitz N, Chalid A, Hummel M, Stein H, Orfanos CE, Goerdt S. Clonal T-cell receptor gamma-chain gene rearrangement by PCR-based GeneScan analysis in the skin and the blood of patients with parapsoriasis and early stage mycosis fungoides. J Pathol 2002.
17. Assaf C, Hummel M, Dippel E, Goerdt S, Müller H, Orfanos C, Stein H. High detection rate of T-cell receptor beta chain rearrangements in T-cell lymphoproliferations by family specific polymerase chain reaction in combination with the GeneScan technique and DNA sequencing. Blood 2000; 96: 640-646.
18. Muche JM, Lukowsky A, Asadullah K, Gellrich S, Sterry W. Demonstration of frequent occurrence of clonal T cells in the peripheral blood of patients with primary cutaneous T-cell lymphoma. Blood 1997; 90: 1636-1642.
19. Dippel E, Schrag H, Goerdt S, Orfanos CE. Extracorporeal photopheresis and interferon-alpha in advanced cutaneous T-cell lymphoma. Lancet 1997; 350: 32-33.
20. Orfanos CE, Garbe C. Pseudolymphome, Praelymphome und Lymphome der Haut. In: Orfanos CE: Therapie der Hautkrankheiten. Berlin, Heidelberg: Springer-Verlag, 1995: 987-1020.
21. Stadler R, Otte HG, Luger T, Henz BM, Kuhl P, Zwingers T, Sterry W. Prospective randomized multicenter clinical trial on the use of interferon-2a plus acitretin versus interferon-2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II. Blood 1998; 92: 3578-3581.
22. Edelson R, Berger C, Gasparro F, Jegasothy B, Heald P, Wintroub B, Vonderheid E, Knobler R, Wolff K, Plewig G. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. N Engl J Med 1987; 316: 297-303.
23. Kaye FJ, Bunn PAJ, Steinberg SM, Stocker JL, Ihde DC, Fischmann AB, Glatstein EJ, Schechter GP, Phelps RM, Foss FM. A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides. N Engl J Med 1989; 321: 1784-1790.
24. Duvic M, Martin AG, Kim Y, Olsen E, Wood GS, Crowley CA, Yocum RC. Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma. Arch Dermatol 2001; 137: 581-593.
25. Olsen E, Duvic M, Frankel A, Kim Y, Martin A, Vonderheid E, Jegasothy B, Wood GS, Gordon M, Heald P, Oseroff A, Pinter-Brown L, Bowen GM, Fivenson DP, Foss F, Glode M, Molina A, Knobler E, Stewart S, Stevens S, Craig F, Reuben J, Bacha P, Nichols J. Pivotal phase III trail of two dose levels of denileukin diftitoxin treatment of cutaneous T-cell lymphoma. J Clin Oncol 2001; 19: 376-388.